Probio’s Series C Financing

Paul Hastings LLP advised GenScript Biotech Corporation and and its subsidiary Probio Technology Limited on the deal. GenScript ProBio announced its Series C round of financing...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Hillhouse’s Investment in GenScript Biotech Corporation

Paul Hastings advised GenScript Biotech Corporatio on the deal. GenScript Biotech Corporation (HKEX Stock Code: 1548.HK) and its indirect wholly-owned subsidiary Probio Technology Limited (“Probio”) announced a Series...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here